Market revenue in 2023 | USD 124.3 million |
Market revenue in 2030 | USD 186.3 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Chemotherapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.87% in 2023. Horizon Databook has segmented the Saudi Arabia home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia has relatively small geriatric population as compared to the Arab world. According to World Bank Group, in 2019, Saudi Arabia’s population aged 65 & above accounted for nearly 3.4% of the total population, while Arab world’s population aged 65 & above accounted for nearly around 4.7% of the total population. Relatively low geriatric population is anticipated to hamper the demand for home infusion services, especially with respect to elderly care services.
According to the Minister of Public Health, obesity, diabetes, cancer, high blood pressure, and high cholesterol are major issues that the country is addressing currently. Approximately 397,000 people have uncontrolled diabetes, thus the demand for insulin infusion pumps has increased in the country. Ischemic heart disease accounted for 25.4% of deaths in 2018, according to the Institute of Health Metrics and Evaluation. More than 2,000 cardiac heart surgeries were performed in the country in 2019. High prevalence of chronic diseases is anticipated to fuel the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account